General Information of This Metabolic Reaction (MR) (ID:
MR001171) |
Formula |
|
Reactant |
Imrecoxib metabolite M2 |
Product |
Imrecoxib metabolite M6 |
Reactant Info
|
Product Info
|
Metabolic Type
|
Conjugation
-
Glucuronidation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Produce The Reactant of This MR
|
|
References |
1 |
Differences in the In Vivo and In Vitro Metabolism of Imrecoxib in Humans: Formation of the Rate-Limiting Aldehyde Intermediate Drug Metab Dispos. 2018 Sep;46(9):1320-1328. doi: 10.1124/dmd.118.081182.
|
2 |
Comparative Pharmacokinetics and Safety of Imrecoxib, a Novel Selective Cyclooxygenase-2 Inhibitor, in Elderly Healthy Subjects. Drug Des Devel Ther. 2022 Nov 8;16:3865-3876. doi: 10.2147/DDDT.S387508.
|
3 |
Metabolism and excretion of imrecoxib in rat Xenobiotica. 2006 May;36(5):441-55. doi: 10.1080/00498250600595524.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.